Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splenic macrophage-B cell axis drives systemic autoimmune-like pathology in Cerebral Malaria.

Nature communications·2026
Same author

Fangchinoline Activates cGAS-STING to Promote Antitumor Immunity without Pathological Inflammation.

International journal of biological sciences·2026
Same author

Bridging antiviral drug discovery with a large language model-powered framework.

Communications biology·2026
Same author

MNS induces antiviral protection and suppresses inflammation.

Annals of medicine·2026
Same author

Betrixaban activates cGAS-STING to promote antitumor immunity without pathological inflammation.

EMBO molecular medicine·2026
Same author

IgG Propels Atherosclerosis by Noncanonically Activating Macrophages.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 14, 2026

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
09:36

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures

Published on: March 10, 2021

3.2K

VDLIN: A Deep Learning-Based Platform for Methylcobalamin-Inspired Immunomodulatory Compound Screening.

Xuefei Guo1, Yang Zhao1, Xianle Rong2

  • 1Institute of Systems Biomedicine, Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, NHC Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, 100191, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|October 27, 2025
PubMed
Summary

Methylcobalamin (MCB) reduces inflammation but weakens innate immunity. A new compound, Co7, balances these effects, offering a promising therapeutic for inflammatory diseases and COVID-19.

Keywords:
EGR1NF‐κBTLR4Vitamin B12 (VB12)convolutional neural networkinflammatory responseinnate immunity

More Related Videos

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

3.0K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
09:36

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures

Published on: March 10, 2021

3.2K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

3.0K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.7K

Area of Science:

  • Immunology
  • Molecular Biology
  • Computational Biology

Background:

  • Methylcobalamin (MCB), an active Vitamin B12 (VB12) form, showed anti-inflammatory potential during COVID-19.
  • MCB treatment may impair macrophage-mediated innate immune responses, despite its anti-inflammatory benefits.

Purpose of the Study:

  • To investigate MCB's impact on innate immunity and develop a strategy to overcome its limitations.
  • To identify novel compounds with both anti-inflammatory and immune-boosting properties.

Main Methods:

  • Comprehensive analyses including RNA-seq, ATAC-seq, and CUT&Tag to understand MCB's mechanism.
  • Development of a deep learning model, VDLIN (Vitamin B12-derived Deep Learning for Innate Immunity), for compound screening.
  • Identification and characterization of a novel compound, Co7.

Main Results:

  • MCB reduces inflammation by limiting chromatin accessibility at NF-κB and EGR1 binding sites, decreasing IFNB1 production and enhancing viral immune evasion.
  • VDLIN successfully identified Co7, which retains MCB's anti-inflammatory effects.
  • Co7 enhances immune activation through the TLR4 signaling pathway, unlike MCB.

Conclusions:

  • MCB's dual effect on inflammation and innate immunity is mediated by chromatin dynamics.
  • Co7 represents a promising therapeutic candidate, balancing anti-inflammatory and immune-stimulatory functions for inflammatory diseases and SARS-CoV-2 infection.
  • This study highlights new therapeutic opportunities by understanding the interplay between chromatin and immune regulation.